Skip to main content

Improved monitoring of 2-Hydroxyglutarate to stage response of combined Vorasidenib and Tumor Specific Peptide Vaccine therapies in recurrent IDH1 mutant lower grade glioma

Research Grant
Duke Scholars

Administered By

Radiology

Awarded By

National Cancer Institute

Start Date

September 21, 2022

End Date

August 31, 2026
 

Administered By

Radiology

Awarded By

National Cancer Institute

Start Date

September 21, 2022

End Date

August 31, 2026